Plancorp LLC’s Immunogen Inc IMGN Stock Holding History

Plancorp LLC’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,000	Closed	-$237K	–	304
2023 Q4	$237K	Buy	+8,000	New	+$159K	0.01%	248
2021 Q2	–	Sell	-14,000	Closed	-$113K	–	223
2021 Q1	$113K	Hold	14,000	–	–	0.02%	203
2020 Q4	$90K	Hold	14,000	–	–	0.02%	196
2020 Q3	$50K	Buy	+14,000	New	+$56.5K	0.02%	185

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Plancorp LLC's IMGN Position: Q1 2024 in Review

Plancorp LLC sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 8,000 shares — an estimated $237K sold.

Plancorp LLC first reported a position in IMGN in Q3 2020 and held it in 4 quarters. The position peaked at $237K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

Plancorp LLC reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
Plancorp LLC sold 8,000 Immunogen Inc shares in Q1 2024, an estimated $237K.
Plancorp LLC first reported a position in Immunogen Inc in Q3 2020 and held it in 4 quarters.
Plancorp LLC's Immunogen Inc position peaked at $237K in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Plancorp LLC's 13F filing for Q1 2024, filed 15 May 2024.